Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
2.510
+0.110 (4.58%)
Feb 4, 2025, 4:00 PM EST - Market closed
Aclaris Therapeutics Employees
As of December 31, 2023, Aclaris Therapeutics had 91 total employees, including 86 full-time and 5 part-time employees. The number of employees decreased by 14 or -13.33% compared to the previous year.
Employees
91
Change (1Y)
-14
Growth (1Y)
-13.33%
Revenue / Employee
$297,571
Profits / Employee
-$406,637
Market Cap
268.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ACRS News
- 5 days ago - Aclaris Therapeutics Announces Formation of New Scientific Advisory Board - GlobeNewsWire
- 4 weeks ago - Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy - Benzinga
- 2 months ago - Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments - Benzinga
- 2 months ago - Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets - PRNewsWire
- 2 months ago - Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline - GlobeNewsWire
- 2 months ago - Aclaris Therapeutics Announces $80 Million Private Placement - GlobeNewsWire